CTNNB1 and ovarian carcinoma: Aberrant immunohistochemical expression of β-catenin (nuclear/cytoplasmatic) has also been demonstrated as a surrogate for β-catenin gene (CTNNB1) mutations in ovarian carcinoma [4,36,37].